Researchers from the University of Auckland and Duke University Medical Centre have collaborated to develop a new understanding and possible way of treating tuberculosis.

A New Zealand-designed compound that shows promise against treatment-resistance tuberculosis (TB) has been selected as a drug candidate by international non-profit drug developer the Global Alliance for TB Drug Development (TB Alliance).